Brief: Firebrick Pharma Seeks Trading Halt
05/06/2025 24:10
June 5 (Reuters) - Firebrick Pharma Ltd FRE.AX: SEEKS TRADING HALT PENDING ANNOUNCEMENT ON SHARE PLACEMENT Further company coverage: FRE.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Firebrick Pharma
See all newsAustralia's Firebrick Pharma jumps on plan to launch Nasodine products in US retail market
Brief: Firebrick Pharma Receives A$293,000 Research And Development Tax Incentive
Brief: Firebrick Pharma Says Nasodine Composition Patent Granted In New Zealand
Brief: Firebrick Pharma Says Nasodine Patent Accepted In Canada
Brief: Firebrick Pharma Secures A$1.5 Million Via Placement